Recently approved Central Nervous System devices in the market
An in-depth Assessment of the Top Drugs Launched by Leading Global Companies in the First Half of 2021 (H1)
pharma-news-for-biogen-eisai-quidel-accutar-boehringer
Biogen-Eisai’s Aduhelm; Quidel ...

Biogen-Eisai's potential Aduhelm sequel drug secured speedy review by FDA Biogen and Eisai’s Alzheimer’s di...

pharma-news-for-aslan-iqvia-reata-recordati-eusa
Aslan Pharma – IQVIA collaborat...

Aslan Pharmaceuticals enters into a strategic collaboration with IQVIA   ASLAN Pharmaceuticals an...

medtech-news-for-lensgen-ge-nevro-hyperfine-immunexpress
LensGen’s Juvene Intraocular Lens; Ne...

Canon Medical launches super-resolution deep-learning reconstruction for Cardiac CT scans  On November...

medtech-news-for-neurent-theradaptive-hagar-fujifilm-brain-navi
Neurent Medical’s NEUROMARK; Brain Navi NaoTrac received European CE Mark approval; Theradaptive ...

Neurent Medical obtains FDA Clearance for NEUROMARK™, a novel multi-point Nerve Disruption Treatment for Chronic Rhinitis   On November 18, 2021, Neurent Medical, a company wor...


medtech-news-for-tectraum-vektor-medtronic-alcon-philips-sight-sciences
TecTraum’s pro2cool receives Breakthrough Device Designation; Vektor Obtains FDA Clearance for vM...

TecTraum’s pro2cool® receives FDA Breakthrough Device Designation for the Concussions treatment   On November 03, 2021, TecTraum Inc., working to develop the world’s first point-of-care treatme...


medtech-news-updates-for-renew-bioscience-perimeter-medical-smithnephew-perimeter-medical-imaging-ai-saga-diagnostics-astrazeneca-magnus-medical-revalve-solutions
Smith+Nephew’s LEGION CONCELOC; Renew Bioscience’s Cerezen; Perimeter Medical’s...

ReValve Solutions, Inc. declares successful first human use of the Transeptal Mitral Valve Replacement  On November 01, 2021, ReValve Solutions, Inc., a company operating in the field of transc...


Fda-Approved-Top-Drugs-Launched-in-2021
An in-depth Assessment of the Top Drugs Launched by Leading Global Companies in the First Half of...

Progress is driven by innovation. When it comes to developing novel medications and therapeutic biological products, the FDA's Center for Drug Evaluation and Research (CDER) assists the pharmaceut...


recent-pharma-news-for-biogen-phathom-vertex-natera
Biogen’s ALS drug Tofersen (BIIB067); Phathom’s erosive esophagitis drug trial; Verte...

Biogen’s tofersen fails to meet the primary goal in the Phase III ALS trial Biogen has announced that its investigational antisense drug, tofersen (BIIB067), flunked to meet the primary goal of...


recent-biotech-pharma-news-for-brickell-bms-amydis-gensight-cybrexa
Brickell to Submit New Drug Application to FDA; Twin Health Raises $140M; BMS’ Deucravaciti...

Brickell Plans to Submit New Drug Application to FDA for gel Brickell Biotech will request the FDA in mid-2022 to approve its gel for excessive underarm sweating after decreasing sweat producti...


Editor's Pick
22 Healthcare Trends & Innovations to Watch in 2022 and Beyond

With the advent of new-age healthcare industry trends that are evident as of now, there...

Assessment of Key Products that Got FDA Approval in Second Half (H2) of 2021

Although COVID-19 continued to dominate headlines in 2021, pharmaceutical companies did...

Analyzing the Key Trends Driving the Biosimilar Market Growth

The Biosimilars market is growing at a breakneck pace. The biosimilar market provides a...

CAR-T Cell Therapy aka Miraculous Technology: Mapping the Market, Approved Th...

Chimeric antigen receptor T-cell (CAR T) therapies are shown to have transformative pot...

Myelodysplastic Syndromes (MDS): Key Pharma Players Unveiling Updated Finding...

There has been limited progress in the approval of novel agents in MDS. It has been a l...